ACTA ENDOCRINOLOGICA-BUCHAREST, vol.13, no.4, pp.393-399, 2017 (Peer-Reviewed Journal)
Introduction. Irisin is a recently discovered novel adipomyokine that induces an increase in total body energy expenditure, improves insulin sensitivity and glucose tolerance. It has been shown that circulating levels of irisin are low in patients with obesity, diabetes mellitus and impaired glucose tolerance. However, the information about the level of circulating irisin in gestational diabetes mellitus (GDM) is controversial.